49 related articles for article (PubMed ID: 21711077)
1. Pathways, outcomes, and costs in colon cancer: retrospective evaluations in 2 distinct databases.
Hoverman JR; Cartwright TH; Patt DA; Espirito JL; Clayton MP; Garey JS; Kopp TJ; Kolodziej M; Neubauer MA; Fitch K; Pyenson B; Beveridge RA
Am J Manag Care; 2011 May; 17 Suppl 5 Developing():SP45-52. PubMed ID: 21711077
[TBL] [Abstract][Full Text] [Related]
2. Pathways, outcomes, and costs in colon cancer: retrospective evaluations in two distinct databases.
Hoverman JR; Cartwright TH; Patt DA; Espirito JL; Clayton MP; Garey JS; Kopp TJ; Kolodziej M; Neubauer MA; Fitch K; Pyenson B; Beveridge RA
J Oncol Pract; 2011 May; 7(3 Suppl):52s-9s. PubMed ID: 21886520
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy for colon cancer--analysis of treatment costs from the perspective of statutory sickness funds.
Görner M; Riemer-Hommel P
Z Gastroenterol; 2008 Jul; 46(7):681-8. PubMed ID: 18618379
[TBL] [Abstract][Full Text] [Related]
4. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
5. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
[TBL] [Abstract][Full Text] [Related]
6. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.
Zuckerman IH; Rapp T; Onukwugha E; Davidoff A; Choti MA; Gardner J; Seal B; Mullins CD
J Am Geriatr Soc; 2009 Aug; 57(8):1403-10. PubMed ID: 19563521
[TBL] [Abstract][Full Text] [Related]
7. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US.
Aballéa S; Chancellor JV; Raikou M; Drummond MF; Weinstein MC; Jourdan S; Bridgewater J
Cancer; 2007 Mar; 109(6):1082-9. PubMed ID: 17265519
[TBL] [Abstract][Full Text] [Related]
9. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
[TBL] [Abstract][Full Text] [Related]
10. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
[TBL] [Abstract][Full Text] [Related]
11. Comparison of costs for infusion versus bolus chemotherapy administration: analysis of five standard chemotherapy regimens in three common tumors--Part one. Model projections for cost based on charges.
Lokich JJ; Moore CL; Anderson NR
Cancer; 1996 Jul; 78(2):294-9. PubMed ID: 8674006
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits.
Uyl-de Groot CA; Vermorken JB; Hanna MG; Verboom P; Groot MT; Bonsel GJ; Meijer CJ; Pinedo HM
Vaccine; 2005 Mar; 23(17-18):2379-87. PubMed ID: 15755632
[TBL] [Abstract][Full Text] [Related]
13. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
[TBL] [Abstract][Full Text] [Related]
14. Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population.
Tournier M; Moride Y; Crott R; du Fort GG; Ducruet T
J Affect Disord; 2009 May; 115(1-2):160-6. PubMed ID: 18694602
[TBL] [Abstract][Full Text] [Related]
15. Assessment of time to follow-up visits in newly-treated hypertensive patients using an electronic medical record database.
Brixner DI; McAdam-Marx C; Ye X; Lau H; Munger MA
Curr Med Res Opin; 2010 Aug; 26(8):1881-91. PubMed ID: 20528221
[TBL] [Abstract][Full Text] [Related]
16. Economic impact of alternative adjuvant chemotherapy regimens for stage III colon cancer.
Goerner M; Riemer-Hommel P
Onkologie; 2009 Nov; 32(11):647-52. PubMed ID: 19887868
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000.
McNaughton-Collins M; Walker-Corkery E; Barry MJ
J Natl Cancer Inst Monogr; 2004; (33):78-101. PubMed ID: 15504921
[TBL] [Abstract][Full Text] [Related]
18. A critical appraisal of treatment for T3N0 colon cancer.
Yo IS; Opelka FG; Bolton JS; Fuhrman GM
Am Surg; 2001 Feb; 67(2):143-8. PubMed ID: 11243538
[TBL] [Abstract][Full Text] [Related]
19. Use of diagnostic cluster methodology for therapeutic costing and drug surveillance of HMG-CoA reductase-inhibitor therapy.
Bottorff MB; Yenkowsky JP; Cave DG
Clin Ther; 1999 Jan; 21(1):218-35. PubMed ID: 10090437
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database.
Sadetsky N; Elkin EP; Latini DM; DuChane J; Carroll PR;
Prostate Cancer Prostatic Dis; 2008; 11(3):280-7. PubMed ID: 17893700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
